Analysis of different Bcl-2 family proteins showed that PUMA induction and Mcl-1 degradation are critical events in regorafenib-induced apoptosis in CRC cells (Figure S2A) 9, 23. The gene discussed is MCL1; the disease is colorectal carcinoma.